Last reviewed · How we verify

NCT03988959

Surgical Management of Multiple Mucoepidermoid Carcinoma and Adenocarcinoma

Completed NA Last updated 18 June 2019
What this trial tests

NA trial testing resection of mucoeidermoid carcinoma in Adenocarcinoma; Mucoepidermoid Carcinoma in 7 participants. Completed in 1 June 2019.

Timeline
1 January 2019
Primary endpoint
1 June 2019
1 June 2019

Quick facts

Lead sponsorAin Shams University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment7
Start date1 January 2019
Primary completion1 June 2019
Estimated completion1 June 2019
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Ain Shams University

Who can join

Adults 20 to 80, any sex, with Adenocarcinoma; Mucoepidermoid Carcinoma. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

A case series of patient having mucoepidermoid carcinoma, had standard treatment protocol and surgeries and followup was performed and the patient postoperative quality of life and recurrent rate was recorded

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Ain Shams University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03988959.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing